Role for metallothioneins-I/II in isoflurane preconditioning of primary murine neuronal cultures

Anesthesiology

Volumn 110, Issue 3, 2009, Pages 538-547

  Edmands, Scott D ^a,b   Hall, Adam C ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b SMITH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; ISOFLURANE; LACTATE DEHYDROGENASE; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN II; MICROTUBULE ASSOCIATED PROTEIN 2; GLUCOSE; METALLOTHIONEIN; OXYGEN;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; ENZYME RELEASE; GLIA CELL; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL HYPOXIA; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CELL HYPOXIA; CELLS, CULTURED; GLUCOSE; ISOFLURANE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; OXYGEN;

EID: 62349083793     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181974bba     Document Type: Article

References (41)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-36
2. Kapinya KJ, LowlD,Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U: Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002; 33:1889-98
3. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt P, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 2004; 100:525-31
4. Murphy E: Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2004; 94:7-16
5. Baxter GF, Goma FM, Yellon DM: Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997; 92:159-67
6. Bolli R: The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an over view. Basic Res Cardiol 1996; 91:57-63
7. Zhao P, Peng L, Li L, Xu X, Zuo Z: Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007; 107:963-70
8. Kitano H, Kirsch JR, Hurn PD, Murphy SJ: Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007; 27:1108-28
9. Hawaleshka A, Jacobsohn E: Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 1998; 45:670-82
10. Lange M, Roewer N, Kehl F: Anesthetic preconditioning as the alternative to ischemic preconditioning. J Thorac Cardiovasc Surg 2006; 131:252-3
11. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87:361-70
12. Sakai H, Sheng H, Yates RB, Ishida K, Pearlstein RD, Warner DS: Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007; 106:92-9
13. Zheng S, Zuo Z: Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 2004; 65:1172-80
14. Bickler PE, Zhan X, Fahlman CS: Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mi-togen-activated protein kinase signaling. Anesthesiology 2005; 103:532-9
15. Dirnagl U, Meisel A: Endogenous neuroprotection: Mitochondria as gateways to cerebral preconditioning? Neuropharmacology 2008; 55:334-44
16. Edmands SD, LaDow ES, Hall AC: DNA microarray analysis of transcriptional response to the inhaled anesthetic isoflurane in rat liver, kidney and heart (abstract). Anesthesiology 2005; 103:A670
17. Carmel JB, Kakinohana o, Mestril R, Young W, Marsala M, Hart RP: Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord. Exper Neurol 2004; 185:81-96
18. Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I, Azuma J: STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res 2005; 65:428-35
19. Wakida K, Shimazawa M, Hozumi I, Satoh M, Nagase H, Inuzuka T, Hara H: Neuroprotective effect of erythropoietin, and role of metallothionein-1 and-2, in permanent focal cerebral ischemia. Neuroscience 2007; 148:105-14
20. Tomita K, Azuma T, Kitamura N, Tamiya G, Ando S, Nagata H, Kato S, Inokuchi S, Nishimura T, Ishii H, Hibi T: Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein. Am J Physiol Gastrointest Liver Physiol 2004; 287:G1078-85
21. Carrier RL, Ma TC, Obrietan K, Hoyt KR: A sensitive and selective assay of neuronal degeneration in cell culture. J Neurosci Methods 2006; 154:239-44
22. Jasani B, Schmid KW: Significance of metallothionein overexpression in human tumours. Histopathology 1997; 31:211-4
23. Kim YH, Kim EY, Gwag BJ, Sohn S, KohJY: Zinc-induced cortical neuronal death with features of apoptosis and necrosis: Mediation by free radicals. Neuroscience 1999; 89:175-82
24. Palmiter RD: Protection against zinc toxicity by metallothionein and zinc transporter 1. Proc Natl Acad SciUSA2004; 101:4918-23
25. Kennette W, Collins oM, Zalups RK, Koropatnick J: Basal and zinc-induced metallothionein in resistance to cadmium, cisplatin, zinc, and tertbutyl hydroper-oxide: Studies using MT knockout and antisense-downregulated MT in mammalian cells. Toxicol Sci 2005; 88:602-13
26. Hidalgo J, Penkowa M, Giralt M, Carrasco J, Molinero A: Metallothionein expression and oxidative stress in the brain. Meth Enzymol 2002; 348:238-49
27. Lu H, Hunt DM, Ganti R, Davis A, Dutt K, AlamJ, Hunt RC: Metallothionein protects retinal pigment epithelial cells against apoptosis and oxidative stress. Exp Eye Res 2002; 74:83-92
28. Hidalgo J, AschnerM, Zatta P, Vasak M: Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 2001; 55:133-45
29. Nishimura N, Nishimura H, Ghaffar A, Tohyama C: Localization of metal-lothionein in the brain of rat and mouse. J Histochem Cytochem 1992; 40:309-15
30. Wakeno-Takahashi M, Otani H, Nakao S, Imamura H, Shingu K: Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart. Am J Physiol Heart Circ Physiol 2005; 289:H2585-91
31. Riess ML, Stowe DF, WarltierDC: Cardiac pharmacological preconditioning with volatile anesthetics: From bench to bedside? Am J Physiol Heart Circ Physiol 2004; 286:H1603-7
32. Penkowa M: Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J 2006; 273:1857-70
33. Campagne MV, Thibodeaux H, van Bruggen N, Cairns B, Lowe DG: Increased binding activity at an antioxidant-responsive element in the metallo-thionein-1 promoter and rapid induction of metallothionein-1 and-2 in response to cerebral ischemia and reperfusion. J Neuroscience 2000; 20:5200-7
34. Kang YJ, Li Y, Sun X, Sun X: Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. Am J Pathol 2003; 163:1579-86
35. Ogawa T, Mimura Y: Antioxidant effect of zinc on acute renal failure induced by ischemia-reperfusion injury in rats. Am J Nephrol 1999; 19:609-14
36. Chung RS, Penkowa M, Dittmann J, King CE, Bartlett C, Asmussen JW, Hidalgo J, Carrasco J, Leung YK, Walker AK, Fung SJ, Dunlop SA, Fitzgerald M, Beazley LD, Chuah MI, Vickers JC, West AK: Redefining the role of metallothionein within the injured brain: Extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. JBiol Chem 2008; 283:15349-58
37. St Croix CM, Stitt MS, Watkins SC, Pitt BR: Fluorescence resonance energy transfer-based assays for the real-time detection of nitric oxide signaling. Methods Enzymol 2005; 396:317-26
38. Stitt MS, Wasserloos KJ, Tang X, Liu X, Pitt BR, St Croix CM: Nitric oxideinduced nuclear translocation of the metal responsive transcription factor, MTF-1 is mediated by zinc release from metallothionein. Vascul Pharmacol 2006; 44:149-55
39. Sato M, Kondoh M: Recent studies on metallothionein: Protection against toxicity of heavy metals and oxygen free radicals. TohokuJExp Med 2002; 196:9-22
40. Kondoh M, Inoue Y, Atagi S, Futakawa N, Higashimoto M, Sato M: Specific induction of metallothionein synthesis by mitochondrial oxidative stress. Life Sci 2001; 69:2137-46
41. Andreini C, Banci L, Bertini I, Rosato A: Counting the zinc-proteins encoded in the human genome. J Proteome Res 2006; 5:196-201